From 2014-16, the Academy undertook a project exploring how the UK’s research environment needs to adapt to meet the health challenges the population will face by 2040. This piece of work is now being revisited in light of the COVID-19 pandemic and changes to the UK's public health structures.
Status: Revisiting
Read more
The Academy is providing input into the Government's Science and Innovation Strategy 2014, including the consultation on long-term capital expenditure.
Status: Ongoing
Read more
The Academy was previously a member of the NICE Implementation Collaborative (NIC), a group that aimed to understand and analyse the barriers that exist to the implementation of NICE recommendations.
Status: Completed
Read more
The Academy believes that the existence, methods and results of clinical and health research involving patients - whether positive or negative - should be made swiftly available for patient, social and scientific benefit.
Status: Ongoing
Read more
In 2012, the Academy responded to a consultation from the Medicine and Healthcare product Regulatory Agency regarding an 'Early Access to Medicines Scheme' that aims to 'bring access to certain new medicines before they are formally licensed'.
Status:
Read more
Global health partnerships and capacity building
Status: Completed
Read more
Work to ensure that the European Data Protection Regulation does not prevent important health research
Status: Ongoing
Read more
The Academy of Medical Sciences has worked to outline the benefits of stratified approaches to medicine, and to address barriers to their widespread development and adoption.
Status:
Read more
View staff bio